Endocrine-Related Cancer

Papers
(The TQCC of Endocrine-Related Cancer is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Acknowledgement to reviewers98
Refining long-term surveillance requirements in patients with differentiated thyroid cancer82
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression61
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms51
Acknowledgement to reviewers45
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs45
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients44
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas39
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications38
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing38
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells31
Update on the genetics of paragangliomas31
Prognostic of recurrence and survival in poorly differentiated thyroid cancer31
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells30
Survival following resection of 10,244 lung neuroendocrine tumours: a population study30
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas30
Targeting growth hormone in cancer: future perspectives30
Metabolically active brown adipose tissue in PPGL: an observational cohort study26
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts26
Radioiodine treatment: an historical and future perspective26
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation25
Peptide receptor radionuclide therapy in malignant insulinoma24
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells24
Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer23
CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours23
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation23
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet23
lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells22
Antitumor immune response is associated with favorable survival in GEP-NEN G322
Gender-affirming care and endocrine-related cancers21
Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma21
Whole-exome sequencing of rectal neuroendocrine tumors21
Rising incidence of follicular thyroid carcinoma and oncocytic carcinoma of the thyroid in Australia20
Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective20
RET signalling in the pituitary: a double-edged sword for differentiation, apoptosis and therapeutic strategies in acromegaly20
Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen18
Distortion in transmission of pathogenic SDHB- and SDHD-mutated alleles from parent to offspring17
Bone metastasis in endocrine-related cancer: unravelling invasion and destruction16
Effect of TSH levels during active surveillance of PTMC according to age15
Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis15
Immunotherapy for endocrine tumours: a clinician’s perspective14
Exploring stem cell biology in pituitary tumors and derived organoids14
ThyroidPrint®: clinical utility for indeterminate thyroid cytology14
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study14
The role of the tumor microenvironment in papillary thyroid microcarcinoma nodal metastasis14
From bench to bedside in the sella: translational developments in pituitary tumour genetics14
Acknowledgement to reviewers13
Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer13
Acknowledgement to reviewers13
Steroid profile in patients with breast cancer and in mice treated with mifepristone13
Clinical features of plurihormonal pituitary adenoma subtypes13
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors13
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms13
Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review12
Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma12
New therapeutic opportunities for women with low-grade serous ovarian cancer12
Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma12
Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000–2020: a population-based retrospective cohort study12
Inhibition of GATA2 in prostate cancer by a clinically available small molecule12
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer12
Diagnosis and management of parathyroid carcinoma: a state-of-the-art review11
Mammary gland development and EDC-driven cancer susceptibility in mesenchymal ERα-knockout mice11
Insights on epidemiology, morbidity and mortality of Cushing’s disease in Northern Ireland11
Systems biology successes and areas for opportunity in prostate cancer11
Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma11
Cancer in Ecuadorian subjects with Laron syndrome (ELS)11
Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity11
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management11
Sexual dimorphism in thyroid cancer: evidence from preclinical studies11
In vivo and in vitro analysis of functional effects of the SDHD H50R variant11
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus11
Genetic disorders and insulinoma/glucagonoma11
Spectrum and carcinogenic properties of thyroglobulin gene fusions in thyroid11
Beyond the three P’s: adrenal involvement in MEN110
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort10
The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal10
Deiodinases in thyroid tumorigenesis10
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms10
Mendelian randomization to investigate the link between TSH and thyroid cancer10
COL12A1 as a prognostic biomarker links immunotherapy response in breast cancer10
Non-pituitary GH regulation of the tissue microenvironment10
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms9
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane9
In memoriam: Charis Eng MD PhD (1962–2024)9
Limited value of genetic profiling in guiding radioiodine therapy for metastatic differentiated thyroid cancer9
MicroRNAs as regulators of tumor metabolism9
The science behind the relations among cancer, height, growth patterns, and growth hormone axis9
miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L29
Genetic variants and down-regulation of CACNA1H in pheochromocytoma9
International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes9
Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis9
Genotype-specific development of MEN 2 constituent components in 683 RET carriers9
Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover8
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma8
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading8
Association of serum steroids with survival in metastatic hormone-sensitive prostate cancer8
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center8
Management of high-grade neuroendocrine neoplasms: impact of functional imaging8
Promoter mutation-independent TERT expression is related to the immune-enriched milieu in papillary thyroid cancer8
Mitochondrial dynamics and oxidative phosphorylation as critical targets in cancer8
Surrogate molecular classification of LAR breast cancer in routine workflow8
Precocious puberty due to intracranial germ cell tumors: a case–control study8
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms8
DNA methylation is a comprehensive marker for pediatric adrenocortical tumors8
0.0782310962677